Comment on: Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection Reply

被引：0
|
作者：
Wefel, Jeffrey S. [1 ]
Noll, Kyle R. [1 ]
Rao, Ganesh [2 ]
Cahill, Daniel P. [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, 1515 Holcombe Blvd,Unit 431, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷 / 04期
关键词：
D O I：
10.1093/neuonc/now296
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：598 / 599
页数：3
相关论文
共 50 条
  • [31] Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the IDH1 Mutation Status
    Uckermann, Ortrud
    Juratli, Tareq A.
    Galli, Roberta
    Conde, Marina
    Wiedemuth, Ralf
    Krex, Dietmar
    Geiger, Kathrin
    Temme, Achim
    Schackert, Gabriele
    Koch, Edmund
    Steiner, Gerald
    Kirsch, Matthias
    CLINICAL CANCER RESEARCH, 2018, 24 (11) : 2530 - 2538
  • [32] Impact of IDH1 mutation on long-term survival in patients with diffuse brain glioma
    Ochirjav, E.
    Choe, G.
    Baldandorj, T.
    Enkhbat, B.
    VIRCHOWS ARCHIV, 2019, 475 : S378 - S378
  • [33] Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients
    Liu, Xipeng
    Liu, Ming
    Cao, Bing
    Qiao, Jianxin
    Zhang, Xiufeng
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (03) : 843 - 847
  • [34] Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status
    Makoto Ohno
    Yoshitaka Narita
    Yasuji Miyakita
    Yoshiko Okita
    Yuko Matsushita
    Akihiko Yoshida
    Shintaro Fukushima
    Koichi Ichimura
    Takamasa Kayama
    Soichiro Shibui
    Brain Tumor Pathology, 2012, 29 : 183 - 191
  • [35] Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status
    Ohno, Makoto
    Narita, Yoshitaka
    Miyakita, Yasuji
    Okita, Yoshiko
    Matsushita, Yuko
    Yoshida, Akihiko
    Fukushima, Shintaro
    Ichimura, Koichi
    Kayama, Takamasa
    Shibui, Soichiro
    BRAIN TUMOR PATHOLOGY, 2012, 29 (04) : 183 - 191
  • [36] PERIPHERAL BLOOD DNA METHYLATION PROFILES IDENTIFY IDH1/2 MUTATION STATUS IN ADULTS WITH DIFFUSE GLIOMA
    Kloetgen, Andreas
    Serrano, Jonathan
    Patel, Seema
    Bowman, Christopher
    Shen, Guomiao
    Zagzag, David
    Karajannis, Matthias
    Golfinos, John
    Placantonakis, Dimitris
    Tsirigos, Aristotelis
    Chi, Andrew S.
    Snuderl, Matija
    NEURO-ONCOLOGY, 2017, 19 : 92 - 92
  • [37] ANALYSIS OF THE BIOCHEMICAL PROFILE OF LOW GRADE GLIOMA WITH DIFFERENT IDH1 MUTATION STATUS USING VIBRATIONAL SPECTROSCOPY
    Uckermann, Ortrud
    Juratli, Tareq
    Conde, Marina
    Galli, Roberta
    Krex, Dietmar
    Geiger, Kathrin
    Schackert, Gabriele
    Temme, Achim
    Steiner, Gerald
    Kirsch, Matthias
    NEURO-ONCOLOGY, 2014, 16
  • [38] Neurocognitive Function in Newly Diagnosed Low-grade Glioma Patients Undergoing Surgical Resection With Awake Mapping Techniques COMMENT
    Sanai, Nader
    NEUROSURGERY, 2015, 77 (03) : 379 - 379
  • [39] Assessing the association between preoperative neurocognitive status and IDH1 mutation status in highgrade gliomas: A deeper look into potential confounding variables
    Khan, Aimen Waqar
    Rizvi, Syed Muhammad Mehdi
    Khan, Abdul Basit
    Din, Maraj Ud
    Abidin, Zain Ul
    NEURO-ONCOLOGY PRACTICE, 2023, 10 (06) : 592 - 592
  • [40] IDH1 STATUS AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR MALIGNANT ASTROCYTOMAS WITH LIMITED HISTOLOGICAL SPECIMEN: THE ROLE OF SURGICAL RESECTION, PATHOLOGICAL ANALYSIS AND MOLECULAR TESTING
    Kim, Betty Y. S.
    Jiang, Wen
    Beiko, Jason
    Prabhu, Sujit
    DeMonte, Franco
    Lang, Frederick
    Gilbert, Mark
    Aldape, Kenneth
    Sawaya, Raymond
    Cahill, Daniel
    McCutcheon, Ian
    NEURO-ONCOLOGY, 2013, 15 : 145 - 145
12345